Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

Published:2006-05-24 Issue:1 Volume:59 Page:17-21
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Park Keon Woo,Ahn Jin Seok,Park Young Suk,Lee Jeeyun,Kang Jung Hoon,Park Joon Oh,Lim Ho Yeong,Im Young-Hyuck,Kang Won Ki,Park Keunchil,Lee Soon Il

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0253-2.pdf

Reference19 articles.

1. Bae JM, Won YJ, Jung KW, Park JG (2002) Annual report of the Korea Central Cancer Registry Program 2000: based on registered data from 131 hospitals. Cancer Res 34:77

2. Pyrhonen S, Kuitunen T, Nyandoto P et al (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587

3. Murad AM, Santiago FF, Petroianu A et al (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gasric cancer. Cancer 72:37

4. Schipper DL, Wagener DJ (1996) Chemotherapy of gastric cancer. Anticancer Drugs 7:137

5. Glimelius B, Ekstrom K, Hoffman K et al (1997) Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8:163

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial;Clinical and Translational Oncology;2019-07-06

2. Gastric/GE Junction Cancer;Clinical Radiation Oncology;2016

3. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer;Cancer Chemotherapy and Pharmacology;2015-08-05

4. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways;Bioscience Reports;2014-03-04

5. Cancer of the Stomach and Gastroesophageal Junction;Abeloff's Clinical Oncology;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3